Navigation Links
Placenta Is A Rich Source Of Blood Stem Cells

Researchers at Children's Hospital Boston and the Dana-Farber Cancer Institute report a surprising finding about embryonic development: the blood system begins to form not only in the embryo itself, but also in the placenta, the organ that nurtures the baby in utero.

Meticulous experiments in mice revealed that the placenta harbors a large supply of hematopoietic (blood-forming) stem cells. These cells, which appear very early in development, are able to generate more blood stem cells and can give rise to a complete blood system when transplanted into an adult. Unlike other sites where blood stem cells are found during embryonic development, such as the liver, the stem cells in the placenta can increase in number without giving rise to mature, specialized cells.

''There must be something unique about the placenta that nurtures blood stem cells and discourages them from differentiating,'' says Dr. Stuart Orkin, a Howard Hughes Medical Institute investigator at Children's and DFCI, and a senior investigator of the study. ''If we figure out what's special about the placental environment, we may learn how to grow blood stem cells in large numbers for clinical application.''

Blood stem cells are used in treating blood cancers like leukemia and other blood diseases, and in patients receiving transplants, but growing them in quantity is difficult. The cells don't multiply readily in the laboratory, so they must be harvested from bone marrow by needle aspiration, a painful procedure, or coaxed into the blood and then collected. Both methods yield only a limited number of blood stem cells.

For more than a decade, scientists have believed that blood stem cells are made only in the embryo itself, within the region of the developing aorta. No role was suspected for the placenta, which has been seen as simply a place for nutrient exchange and waste removal between mother and fetus. But rather than merely providing nutrients, Orkin says, the placent a may also provide an ''infusion'' of blood stem cells to the fetus.

''This research reveals a new organ for blood development,'' Orkin says. ''It is surprising that this role for the placenta has been overlooked for so many years.''

The study, published in the March issue of the journal Developmental Cell, found that blood stem cells appeared in the placenta early, with numbers peaking mid-gestation. Only the fetal liver, where blood stem cells are known to expand tremendously, had greater numbers of blood stem cells.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults for over 136 years. More than 500 scientists, including eight members of the National Academy of Sciences, nine members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Children's research community. Founded in 1869 as a 20-bed hospital for children, Children's Hospital Boston today is a 325-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital visit: http://www.childrenshospital.org/research.


'"/>

Source:Children's Hospital Boston


Related biology news :

1. Source of molecular triggers in cutaneous T cell lymphoma identified
2. Finding Cures For Tropical Diseases: Is Open Source An Answer?
3. Open Source Biotechnology alliance for international agriculture
4. Source of crucial immune cell in the skin discovered
5. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
6. White Blood Cell Waste Disposal System Plays Critical Regulatory Role
7. Mystery Blood Vessel Disorder Implicated In Mini Strokes
8. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
9. Young Blood Revives Aging Muscles, Stanford Researchers Find
10. Stem Cells to Solve the Blood Shortage Problem?
11. Blood flow in brain takes a twist, affecting views of Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology: